Dr. David R. Jones Independent Consultant PharmacoToxicologist, UK

David Jones attended the University College of Wales, Aberystwyth and obtained degrees in chemistry and biochemistry in 1977. He subsequently gained a Master’s Degree in Pharmacological Biochemistry from the University of Hertford in 1986. After 8 years working in contract toxicology and 11 years in the pharmaceutical industry, he joined... read morethe Medicines Control Agency (MCA), the UK’s Regulatory Agency, which subsequently became the Medicines and Healthcare products Regulatory Agency (MHRA). His primary role at the MHRA principally involved assessing nonclinical data for Clinical Trial Authorisation (CTA) Applications and Marketing Authorisation Applications (MAA), both for non-biological and biological products, including advanced therapy medicinal products (ATMPs).

He represented the UK in the European Union Safety Working Party for almost 15 years before the UK left the EU. He was the EU Rapporteur in the ICH revision of the M3 Guideline, on the ICH S10 Guideline, on the Q&A document for ICH S3 (Toxicokinetics) guideline and on the ICH S11 (Nonclinical Studies to Support Paediatric Medicine) guideline, as well having significant input into other nonclinical ICH guidelines.